Association of electrocardiographic and imaging surrogates of left ventricular hypertrophy with incident atrial fibrillation: MESA (Multi-Ethnic Study of Atherosclerosis)
- PMID: 24657688
- PMCID: PMC4024364
- DOI: 10.1016/j.jacc.2014.01.066
Association of electrocardiographic and imaging surrogates of left ventricular hypertrophy with incident atrial fibrillation: MESA (Multi-Ethnic Study of Atherosclerosis)
Abstract
Objectives: This study sought to examine the association between left ventricular hypertrophy (LVH), defined by cardiac magnetic resonance (CMR) and electrocardiography (ECG), with incident atrial fibrillation (AF).
Background: Previous studies of the association between AF and LVH were based primarily on echocardiographic measures of LVH.
Methods: The MESA (Multi-Ethnic Study of Atherosclerosis) enrolled 4,942 participants free of clinically recognized cardiovascular disease. Incident AF was based on MESA-ascertained hospital-discharge International Classification of Diseases codes and Centers for Medicare and Medicaid Services inpatient hospital claims. CMR-LVH was defined as left ventricular mass ≥95th percentile of the MESA population distribution. Eleven ECG-LVH criteria were assessed. The association of LVH with incident AF was evaluated using multivariable Cox proportional hazards models adjusted for CVD risk factors.
Results: During a median follow-up of 6.9 years, 214 incident AF events were documented. Participants with AF were more likely to be older, hypertensive, and overweight. The risk of AF was greater in participants with CMR-derived LVH (hazard ratio [HR]: 2.04, 95% confidence interval [CI]: 1.15 to 3.62). AF was associated with ECG-derived LVH measure of Sokolow-Lyon voltage product after adjusting for CMR-LVH (HR: 1.83, 95% CI: 1.06 to 3.14, p = 0.02). The associations with AF for CMR-LVH and Sokolow-Lyon voltage product were attenuated when adjusted for CMR left atrial volumes.
Conclusions: In a multiethnic cohort of participants without clinically detected cardiovascular disease, both CMR and ECG-derived LVH were associated with incident AF. ECG-LVH showed prognostic significance independent of CMR-LVH. The association was attenuated when adjusted for CMR left atrial volumes.
Keywords: atrial fibrillation; cardiac magnetic resonance imaging; electrocardiography; left ventricular hypertrophy.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Comment in
-
Structural and functional cardiac changes are target organ damage that increases risk of atrial fibrillation.J Am Coll Cardiol. 2014 May 20;63(19):2014-5. doi: 10.1016/j.jacc.2014.02.548. Epub 2014 Mar 19. J Am Coll Cardiol. 2014. PMID: 24657691 No abstract available.
Similar articles
-
Electrocardiographic left ventricular hypertrophy predicts atrial fibrillation independent of left ventricular mass.Ann Noninvasive Electrocardiol. 2017 May;22(3):1-5. doi: 10.1111/anec.12419. Epub 2016 Dec 25. Ann Noninvasive Electrocardiol. 2017. PMID: 28019050 Free PMC article.
-
Left ventricular hypertrophy phenotype to predict incident atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis.Nutr Metab Cardiovasc Dis. 2024 Jun;34(6):1399-1406. doi: 10.1016/j.numecd.2024.01.012. Epub 2024 Jan 12. Nutr Metab Cardiovasc Dis. 2024. PMID: 38402001
-
Diagnostic and prognostic utility of electrocardiography for left ventricular hypertrophy defined by magnetic resonance imaging in relationship to ethnicity: the Multi-Ethnic Study of Atherosclerosis (MESA).Am Heart J. 2010 Apr;159(4):652-8. doi: 10.1016/j.ahj.2009.12.035. Am Heart J. 2010. PMID: 20362725 Free PMC article.
-
Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.J Electrocardiol. 2014 Sep-Oct;47(5):630-5. doi: 10.1016/j.jelectrocard.2014.07.003. Epub 2014 Jul 3. J Electrocardiol. 2014. PMID: 25052475 Review.
-
Angiotensin II receptor blockers and cardiovascular protection: focus on left ventricular hypertrophy regression and atrial fibrillation prevention.Vasc Health Risk Manag. 2008;4(1):67-73. doi: 10.2147/vhrm.2008.04.01.67. Vasc Health Risk Manag. 2008. PMID: 18629360 Free PMC article. Review.
Cited by
-
Clinical utility of electrocardiographic voltage parameters for the diagnosis of hypertrophic cardiomyopathy.Front Cardiovasc Med. 2024 Sep 19;11:1354364. doi: 10.3389/fcvm.2024.1354364. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39386386 Free PMC article.
-
Electrocardiographic Left Ventricular Hypertrophy as a Predictor of Cardiovascular Disease Independent of Left Ventricular Anatomy in Subjects Aged ≥65 Years.Am J Cardiol. 2016 Jun 1;117(11):1831-5. doi: 10.1016/j.amjcard.2016.03.020. Epub 2016 Mar 19. Am J Cardiol. 2016. PMID: 27067620 Free PMC article.
-
The occurrence of postoperative atrial fibrillation according to different surgical settings in cardiac surgery patients.Interact Cardiovasc Thorac Surg. 2012 Dec;15(6):1007-12. doi: 10.1093/icvts/ivs361. Epub 2012 Aug 26. Interact Cardiovasc Thorac Surg. 2012. PMID: 22927177 Free PMC article.
-
Prediction model for the new onset of atrial fibrillation combining features of 24-hour Holter electrocardiogram with 12-lead electrocardiogram.Int J Cardiol Heart Vasc. 2023 Jul 18;47:101245. doi: 10.1016/j.ijcha.2023.101245. eCollection 2023 Aug. Int J Cardiol Heart Vasc. 2023. PMID: 37521520 Free PMC article.
-
Incidence of Atrial Fibrillation in Persons with Very High Serum Levels of N-Terminal Pro-B-Type Natriuretic Peptide: The Multi-Ethnic Study of Atherosclerosis.Clin Epidemiol. 2021 Apr 7;13:265-272. doi: 10.2147/CLEP.S303560. eCollection 2021. Clin Epidemiol. 2021. PMID: 33854380 Free PMC article.
References
-
- Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946–952. - PubMed
-
- Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995;98:476–484. - PubMed
-
- Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002;113:359–364. - PubMed
-
- Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, D'Agostino RB, Massaro JM, Beiser A, Wolf PA, Benjamin EJ. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110:1042–1046. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical